During the process of tumor cell invasion and metastasis, tumor cells are known to interact with extracellular matrix proteins, endothelial cells, platelets and other organ-specific structures. Integrins are cell surface molecules which mediate cell-matrix and cell-cell interactions and are likely to be important for tumor cell survival and dissemination. The purpose of this study was to characterize the integrin and proteolytic enzyme repertoire from low (A375P), medium (A375M) and high metastatic (A375SM) human melanoma cell lines. These cell lines are also invasive through human amniotic membranes in vitro and their invasiveness parallels the reported metastatic phenotype. The types and levels of expression of the various integrin receptors were analysed by quantitative immunoprecipitation using a panel of monoclonal antibodies directed to known integrin subunits. In addition, cDNA probes to the integrin subunits were used in quantitative northern blot analysis. These data show that the integrin αvβ3 increases 50- to 100-fold as these cells progress to a more metastatic phenotype. α4β1 levels also appeared to increase several fold, while other β1 integrins did not differ in their expression levels. The increased αvβ3 expression in the more metastatic cells resulted in an increased adhesion to vitronectin and fibrinogen substrates in cell attachment assays. However, αv- and β3-specific antibodies did not inhibit A375 cell invasion through the amnion. Each cell line was found to release similar quantities of a 72-kDa gelatinase/type IV collagenase and tissue type plasminogen activator. These results suggest that during the progression of these tumor cells from a low to high metastatic phenotype, marked changes in integrin expression occurred which may facilitate interactions with platelets, endothelial cells and specific extracellular matrix proteins to promote metastasis.
Similar content being viewed by others
References
Liotta LA, 1986, Tumor invasion and metastases — role of the extracellular matrix: Rhoads memorial award lecture. Cancer Research, 46, 1–7.
Weiss L, Orr FW and Horn KV, 1989, Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis. Clinical and Experimental Metastasis, 7, 127–167.
Nicolson GL, 1986, Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochimica et Biophysica Acta, 948, 175–224.
Poste G and Fidler IJ, 1980, The pathogenesis of cancer metastasis. Nature, 283, 139–146.
Auerbach R, Lu WC, Pardon E et al., 1987, Specificity of adhesion between murine tumor cells and capillary endothelium: an in vitro correlate of preferential metastasis in vivo. Cancer Research, 47, 1492–1496.
Nicolson GL, 1988, Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Review, 7, 143–188.
Gehlsen KR, Argraves WS, Pierschbacher MD and Ruoslahti E, 1988, Inhibition of tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides. Journal of Cell Biology, 106, 925–930.
Ossowski L and Reich E, 1983, Antibodies to plasminogen activator inhibit tumor metastasis. Cell, 35, 611–619.
Mignatti P, Robbins E and Rifkin DB, 1986, Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell, 47, 487–498.
Liotta LA, Steeg PS and Stetler-Stevenson WG, 1991, Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327–336.
Liotta LA, Tryggvason K, Garbisa S, et al., 1980, Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature, 284, 67–68.
Davis GE and Martin BM, 1990, A latent Mr 94,000 gelatin-degrading metalloprotease induced during differentiation of HL-60 promyelocytic leukemia cells: a member of the collagenase family of enzymes. Cancer Research, 50, 1113–1120.
Hynes RO, 1987, Integrins: a family of cell surface receptors. Cell, 48, 549–554.
Ruoslahti E and Pierschbacher MD, 1987, New perspectives in cell adhesion: RGD and integrins. Science, 238, 491–497.
Albelda SM and Buck CA, 1990, Integrins and other cell adhesion molecules. FASEB Journal, 4, 2868–2880.
Albelda SM, Mette SA, Elder DE, et al., 1990, Integrin distribution in malignant melanoma: association of the β3 subunit with tumor progression. Cancer Research, 50, 6757–6764.
Ginsberg MH, Loftus JC and Plow EF, 1988, Cytoadhesins, integrins, and platelets. Thrombosis and Haemostasis, 59, 1–6.
Humphries MJ, Olden K and Yamada K, 1986, A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science, 233, 467–470.
Carter WG, Wayner EA, Bouchard TS and Taur P, 1990, The role of integrins α2β1 and α3β1 in cell-cell and cell-substrate adhesion of human epidermal cells. Journal of Cell Biology, 110, 1387–1404.
Sorokin L, Sonnenberg A, Aumailley M, Timpl R and Ekblom P, 1990, Recognition of the laminin E8 cell-binding site by an integrin possessing the α6 subunit is essential for epithelial polarization in developing kidney tubules. Journal of Cell Biology, 111, 1265–1273.
Springer TA, 1990, Adhesion receptors of the immune system. Nature, 346, 425–434.
Plantefaber LC and Hynes RO, 1989, Changes in integrin receptors on oncogenically transformed cells. Cell, 56, 281–290.
Heino J and Massagué J, 1989, Transforming growth factor-β switches the pattern of integrins expressed in MG-63 human osteosarcoma cells and causes a selective loss of cell adhesion to laminin. Journal of Biological Chemistry, 264, 21806–21811.
Dedhar S and Saulnier R, 1990, Alterations in integrin receptor expression on chemically transformed human cells: specific enhancement of laminin and collagen receptors. Journal of Cell Biology, 110, 481–489.
Giancotti FG and Ruoslahti E, 1990, Elevated levels of the α5β1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell, 60, 849–859.
Boukerche H, Berthier-Vergnes O, Bailly M, et al., 1989, A monoclonal antibody (LYP18) directed against the blood platelet glycoprotein IIb/IIIa complex inhibits human melanoma growth in vivo. Blood, 74, 909–912.
Kozlowski JM, Hart IR, Fidler IJ and Hana N, 1984, A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. Journal of the National Cancer Institute, 72, 913–917.
Welch DR, Bisi JE, Miller BE, et al., 1991, Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. International Journal of Cancer, 47, 227–237.
Gehlsen KR, Engvall E, Dickerson K, Argraves WS and Ruoslahti E, 1989, Subunit structure of a laminin-binding integrin and localization of its binding site on laminin. Journal of Biological Chemistry, 264, 19034–19038.
Cheresh D and Harper J, 1987, Arg-Gly-Asp recognition by a cell adhesion receptor requires its 130 kDa subunit. Journal of Biological Chemistry, 262, 1434–1437.
Takada Y and Hemler ME, 1989, The primary structure of the VLA-2/collagen receptor α2 subunit (Platelet GPIa): homology to other integrins and the presence of a possible collagen binding domain. Journal of Cell Biology, 109, 397–407.
Takada Y, Elices MJ, Crouse C and Hemler ME, 1989, The primary structure of the α4 subunit of VLA-4: homology to the other integrins and a possible cell-cell adhesion function. EMBO Journal, 8, 1361–1368.
Argraves WS, Suzuki S, Arai H, et al., 1987, Amino acid sequence of the human fibronectin receptor. Journal of Cell Biology, 105, 1183–1190.
Suzuki S, Argraves WS, Arai H, et al., 1987, Amino acid sequence of the vitronectin receptor alpha subunit and comparative expression of adhesion receptor mRNAs. Journal of Biological Chemistry, 262, 14080–14085.
Gehlsen KR and Hendrix MJC, 1986, In vitro assay demonstrates similar invasion profiles for B16F1 and B16F10 murine melanoma cells. Cancer Letters, 30, 207–212.
Hendrix MJC, Gehlsen KR, Wagner HN, et al., 1985, In vitro quantitation of melanoma tumor cell invasion. Clinical and Experimental Metastasis, 3, 221–233.
Heussen C and Dowdle EB, 1980, Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Analytical Biochemistry, 102, 196–202.
Seftor EB, Seftor EA, Gehlsen KR, et al., 1992, Role of the αvβ3 integrin in tumor cell invasion. Proceedings of the National Academy of Science USA, in press.
Wayner EA, Garcia-Pardo A, Humphries MJ, McDonald JA and Carter WG, 1989, Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-2) in plasma fibronectin. Journal of Cell Biology, 109, 1321–1330.
Elices MJ, Osborn L, Takada Y, et al., 1990, VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4 fibronectin binding site. Cell, 60, 577–584.
Rice EG and Bevilacqua M, 1989, An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science, 246, 1303–1306.
Taichman DB, Cybulsky MI, Djaffar I, et al., 1991, Tumor cell surface α4β1 integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the NH2-terminal domains of INCAM-110/VCAM-1. Cell Regulation, 2, 341–355.
Werb Z, Tremble PM, Behrendtsen O, Crowley E and Damsky CH, 1989, Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. Journal of Cell Biology, 109, 877–889.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gehlsen, K.R., Davis, G.E. & Sriramarao, P. Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin Exp Metast 10, 111–120 (1992). https://doi.org/10.1007/BF00114587
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00114587